Melissa Dungan, SLP | |
2498 Dayton Xenia Rd, Beavercreek, OH 45434-7169 | |
(937) 427-1919 | |
Not Available |
Full Name | Melissa Dungan |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 2498 Dayton Xenia Rd, Beavercreek, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215137419 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | SP7465 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Melissa Dungan, SLP 2498 Dayton Xenia Rd, Beavercreek, OH 45434-7169 Ph: (937) 427-1919 | Melissa Dungan, SLP 2498 Dayton Xenia Rd, Beavercreek, OH 45434-7169 Ph: (937) 427-1919 |
News Archive
Haemacure Corporation announces that it has filed a notice of intention to make a proposal to its creditors under the Bankruptcy and Insolvency Act (Canada) and that its wholly-owned U.S. subsidiary sought court protection under Chapter 11 in the United States. The filings were made after the close of markets on Friday, January 8, 2010.
A new American Health Care Association (AHCA) analysis of the pending U.S. House health care reform bill, combined with the impact of a recently-enacted Medicare regulation cutting Medicare-funded nursing home care by $12 billion over ten years, finds seniors in Texas requiring nursing and rehabilitative care will face total funding cuts of more than $2.7 billion over that same time period, which equals the 4th-highest state cut across the 50 states.
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE® (timolol maleate ophthalmic gel forming solution). Timoptic-XE is a non-selective beta-adrenergic receptor blocking agent indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Aton also announced that it will continue to make available branded Timoptic-XE.
Cancer remains the second-leading cause of death in the United States. This year, an estimated 1.7 million new cases will be diagnosed, with nearly 610,000 people expected to die from the disease, according to the National Cancer Institute.
› Verified 6 days ago
Sara Raye Ditzel, MSP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3817 Colonel Glenn Hwy, Beavercreek, OH 45324 Phone: 937-427-9200 | |
Lea Ann Hinkle, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2942 Dayton Xenia Rd, Beavercreek, OH 45434 Phone: 937-429-7588 | |
Kimberlyn Cooper-miller, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3817 Colonel Glenn Hwy, Beavercreek, OH 45324 Phone: 937-427-9200 Fax: 513-755-3762 | |
Megan Strum, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2498 Dayton Xenia Rd, Beavercreek, OH 45434 Phone: 937-427-1919 | |
Ms. Jeannine Danis, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3560 Kemp Rd, Beavercreek, OH 45431 Phone: 937-429-7610 | |
Ms. Adrienne Mann, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3817 Colonel Glenn Hwy, Beavercreek, OH 45324 Phone: 937-427-9200 | |
Julia Laughman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3817 Colonel Glenn Hwy, Beavercreek, OH 45324 Phone: 937-427-9200 |